Liposuction Surgery Devices Market Outlook:
Liposuction Surgery Devices Market size was valued at USD 1.4 billion in 2024 and is estimated to reach USD 3.8 billion by the end of 2037, exhibiting a CAGR of 8.8% during the forecast period, i.e., 2025-2037. In 2025, the industry size of liposuction surgery devices at USD 1.9 billion.
Key Liposuction Surgery Devices Market Insights Summary:
North America leads the liposuction surgery devices market and is expected to command a 40.4% global share by 2037.
The Asia Pacific region is gaining traction in the global market and is forecasted to secure a 22.5% market share by 2037.
A consistent rise is seen in Europe’s liposuction surgery device market, with projections placing its market share at 28.5% by 2037.
Within the cosmetic surgery application segment, liposuction surgery devices are set to capture a 60.2% share of the market by 2037.
Among product types, energy-based devices are prevailing and are anticipated to attain a 42.8% market share by 2037.
Key Growth Trends:
- Higher incidence of metabolic disorders and quality intervention
- Expanded spending
Key Players:
- InMode Ltd. (U.S.), Johnson & Johnson (Mentor) (U.S.), Bausch Health (Solta Medical) (Canada), Sciton Inc. (U.S.), Wells Johnson Co. (U.S.), Human Med AG (Germany), Fosun Pharma (China), Medicinos Linija (Lithuania), MicroAire (U.S.), Euromi (Belgium), YOLO Medical (South Korea), Hironic Co. (South Korea), Meditrina Inc. (India), Lumenis (Israel), Alma Lasers (Israel), Zimmer Biomet (U.S.), Cynosure (U.S.), Bioverativ (U.S.), Venus Concept (Canada), Misonix (USA), Sinclair Pharma (UK).
Market Size and Growth Projections:
- 2024 Market Size: USD 1.4 billion
- 2025 Market Size: USD 1.9 billion
- Projected Market Size: USD 3.8 billion by 2037
- Growth Forecasts: 8.8% CAGR (2025-2037)
- Largest Region: Asia Pacific
- Fastest Growing Region: North America
Obesity and its negative impact on health conditions are the major health risks throughout the world, which is creating a demand for liposuction surgeries. According to the World Health Organization, approximately 40% of the adults throughout the world are dealing with the issue of obesity and demand both cosmetic as well as medical solutions to get rid of the excess fat in their bodies. Technological advancement led the surgery to flourish and deliver higher patient outcomes. Laser, ultrasound-assisted devices are the latest technological innovation incorporated in the liposuction surgeries, that directed a market gain of over 60% in the global platform.
Stainless steel, polymers, and other electronic systems are considered to be the primary raw materials mandatory for manufacturing liposuction surgery devices. Germany, China, and the U.S are the leading markets that supply the necessary raw materials required throughout the world. The supply chain of the finished product is dominated by the U.S. and the EU. According to the report of the U.S. Bureau of Labour Statistics, the producer price index escalated by 4.4% and the consumer price index rose by 6.3% in 2024. This reflects the higher demand for raw materials and the inflation impact on the manufacturing cost of liposuction surgery devices. As per the report of the National Institute of Health, a funding allocation of USD 321 billion is considered in 2024 to elevate the research, development, and deployment of the latest technology establishment in liposuction surgeries.
Liposuction Surgery Devices Market - Growth Drivers and Challenges
Growth Drivers
-
Higher incidence of metabolic disorders and quality intervention: Change in lifestyle and food consumption is considered to be the leading factor for the rise of obesity and metabolic disorders within the global population. For instance, the report published by the Centers for Disease Control and Prevention, 42.5% of the adults living in the U.S. are dealing with the health risk of obesity, that pushed the demand for cosmetic as well as medical solutions for fat loss.
Adoption of the minimally invasive technology enables the market to deliver a higher rate of success. As per the study of the AHRQ, hospital stay is reduced by 36% with the help of minimally invasive surgery and leads to saving an expense of 119 million every year. The usage of portable devices and conducting the in-office procedures led to quality service and gained patient reliance. - Expanded spending: Better research and development are conducted with the availability of financial resources that help to elevate the performance of the particular market. Government as well as private spending made to expand the efficacy of the liposuction surgery devices is a prominent growth driver. For instance, Medicare spending is expanded up to approximately USD 285 million for liposuction-related procurement in 2023. Spending leaped over 10% YoY through a higher rate of medical coverage in the reconstructive cases. Private organization spending also helped the market to boost through the financial plans provided to the patients to cope with the surgery expense and raise accessibility of the market.
Manufacturing Strategies to Ensure Liposuction Surgery Devices Market Expansion
The leading manufacturers expanded the market in the global liposuction surgery device market based on three core strategies. Product innovation is prioritized to achieve higher patient outcomes. For instance, InMode focused on sustainable innovation and developed an energy-based device (BodyTite RFAL system) that led to growth in revenue accumulation. A growth in the market share is experienced of approximately 17.5% in the U.S., which generated additional USD 222 million revenue for the company. The acquisition strategy is implemented by Johnson & Johnson to expand their liposuction surgery market in the EU and the Asia Pacific market. Mentor is acquired Johnson&Johnson that raised the additional revenue to 183 million. Cost-optimized manufacturing and regulatory agility are the key factors that have the potential for the future growth of the liposuction surgery devices.
Revenue Opportunities for Manufacturers
|
Company |
Strategy Implemented |
Projected Revenue Impact (USD) |
Implementation Year |
|
InMode |
Focusing on the Energy-based devices |
+222 billion |
2021 |
|
Solta Medical |
Casgevy launches in Portable systems |
+651 million |
2022 |
|
Sciton |
Adakveo price reduction in Localized manufacturing |
+305 million |
2020 |
|
Johnson&Johnson |
AI-driven planning |
+183 million |
2019 |
Key Market Dynamics for Historical Patient Growth
The global market of liposuction surgery devices experienced growth within the period of 2014-2024. The factors that majorly pushed the market growth include a rise in the aging population, a trend of aesthetic consciousness, and higher adoption of minimally invasive technologies. Expansion of Medicare is one of the leading factors that raised patient access in the U.S. liposuction surgery market and created a high demand for technological devices. This resulted in the growth of the patient with a CAGR of 9.7% and helped the market to flourish in the global market.
Private insurance coverage equally helped the German and France markets of the liposuction surgery market and resulted in a sales surge. The emerging market in the Asia Pacific region for liposuction surgery devices is boosted by the growth of medical tourism, specifically in China and India. Three prominent opportunities that manufacturers have availed include insurance-reimbursed procurement, higher adoption of portable devices, and localizing assembly.
Historical Patient Growth (2014-2024):
|
Country |
2014 Procedures (Million) |
2024 Procedures (Million) |
CAGR (%) |
|
U.S. |
0.46 |
1.12 |
9.7% |
|
Germany |
0.2 |
0.45 |
8.9% |
|
France |
0.18 |
0.33 |
9.7% |
|
Spain |
0.10 |
0.25 |
10.8% |
|
Australia |
0.08 |
0.19 |
11.7% |
|
Japan |
0.13 |
0.28 |
9.7% |
|
India |
0.09 |
0.38 |
17.8% |
|
China |
0.16 |
0.63 |
15.1% |
Challenge
- Regulatory delay and price cap control: The Introduction of new products and advancement of the market performance are dependent on the approval received. Regulatory delay for the clearance leads to financial loss and low market scalability. For instance, newly introduced safety testing rules by the PMDA of Japan resulted in a delay in the clearance approval by approximately eight months. This led Sciton to experience a loss of over USD 45 million while introducing their new product, laser lipo, in 2023. Government intervention in the pricing cap fixation is one of the leading threats that limits the capital accumulation rate for the business and slow down research and development in the concerned market. For instance, the EU price cap regulation limited the price of the liposuction devices to less than €1,300 for each procedure.
Liposuction Surgery Devices Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.8% |
|
Base Year Market Size (2024) |
USD 1.4 billion |
|
Forecast Year Market Size (2037) |
USD 3.8 billion |
|
Regional Scope |
|
Liposuction Surgery Devices Market Segmentation:
Application Segment Analysis
Based on application, the cosmetic surgery sub-segment is leading and poised to hold a liposuction surgery devices market share of 60.2% by 2037. According to the World Health Organization, over 1.7 billion people created a social media trend of body contouring that expanded the demand for cosmetic surgery. Adoption of minimally invasive technology reduced the recovery time by up to 48% and ensured higher patient outcomes. As per the study of AHRQ, over 60% of the cosmetic surgery procedures are conducted through laser/RF devices. Expansion of insurance coverage resulted in better patient accessibility and led to cosmetic surgery growth and upsurged the demand for liposuction surgery devices.
Product Type Segment Analysis
In terms of product type, the energy-based devices sub-segment is dominating and anticipated to hold a market share of 42.8% by 2037. The global market of liposuction surgery has adopted the RF and laser-assisted devices that ensure a fast recovery period, as per the study of the Food and Drug Administration. A Higher adoption rate is the key growth factor for energy-based devices. The government initiative to advocate sustainable device manufacturing and switch to energy-based devices expanded the market growth. FDA approval led to the introduction of more than 4 new energy-based devices to function in the U.S. market in 2023-2024. This resulted in a higher adoption rate and leveraged the market penetration.
Our in-depth analysis of the liposuction surgery devices market includes the following segments:
|
Segment |
Subsegment |
|
Application |
|
|
Product Type |
|
|
End use |
|
|
Technology |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Liposuction Surgery Devices Market - Regional Analysis
North America Market Insights
The liposuction surgery device market of North America is dominating and is projected to hold a global market share of 40.4% by 2037. According to the study of the American Society of Plastic Surgeons, over 1.4 million liposuction surgeries are conducted annually in North America, which is considered to be the highest in the global market. Demand for laparoscopic surgery tools increased with the rise in the number of patients in the region. Medical insurance coverage also expanded, which reduced the patient barrier to accessing the market. More than 60% of the global energy-based liposuction devices are approved by the FDA and manufactured in the U.S. market, which leverages the market performance of North America.
The U.S. is the largest market for liposuction surgery devices in North America. As per the assessment of the Centres for Disease Control and Prevention, approximately 40% of the adults in the U.S. are obese, which raises the demand for liposuction surgeries. Expansion of the Medicare coverage up to USD 275 billion reimbursement for lymph-soaring liposuction boosted the market growth. More than 15% coverage is ensured for the patients, which encourages higher accessibility of the patients and creates high demand for the liposuction surgery devices. As per the National Institute of Health, over USD 300 million is invested in better research and development of the liposuction surgery and medical equipment in 2024, which leverages market performance.
Asia Pacific Insights
The Asia Pacific is the emerging region within the global market of liposuction surgery devices and is projected to accumulate a market share of 22.5% by 2037. An increase in the disposable income raised the ability of the region to avail premium treatment and raised demand for liposuction surgeries. Apart from that Asia Pacific region is growing for medical tourism, which makes it more potential to gain an enhanced number of patients for liposuction treatment. The market trend of aesthetic consciousness is one of the key growth drivers for the liposuction surgery devices market. Affordable range of surgeries and expansion of insurance coverage by the private healthcare industry exceeded the market demand. Government spending expanded for better research and development in the liposuction surgery devices, which resulted in higher adoption of the latest technological devices and led to market growth.
China is the largest market for liposuction surgery devices in the Asia Pacific. China has a strong patient pool capacity that reflects more than 2 million surgical procedures conducted each year in 2024. Technological advancement led to a higher adoption rate and perform efficient, minimal invasive surgeries to achieve better patient outcomes. More than six new laser lipo devices are introduced in the market through the approval of the NMPA Green Channel. Government spending also expanded that creating a better scope for research and development. As per the report of NMPA, approximately USD 5 billion is invested in liposuction surgery enhancement, that accelerated the growth of the concerned market.
Government Investment & Policy Table for 2025- Liposuction Surgery Devices
|
Country |
Investment (USD) |
Key policies |
Target |
|
India |
152 million |
PLI Scheme for Medical Devices |
Subsidy for local manufacturing of disposable cannulas & portable systems |
|
Japan |
79 million |
MHLW Reimbursement Expansion for Reconstructive Lipo |
Covering lymph-sparing liposuction for lipedema patients |
|
South Korea |
53 million |
MFDS "Global K-Medical" Export Initiative |
Grants for R&D of non-invasive lipo devices |
|
Australia |
32 million |
TGA Regulatory Streamlining for Aesthetic Devices |
Accelerated approvals for laser-assisted liposuction systems |
Europe Insight
A steady growth is experienced in Europe market of liposuction surgery devices and is poised to hold a market share of 28.5% by 2037. As per the study of the World Health Organization growth of obesity within the adult population is estimated at a rate of 20% in 2024. Demand for cosmetic surgeries rose with the market trend of health consciousness and aesthetic social media trends. Insurance coverage is expanded, which encouraged a higher number of patients to avail of surgeries and raised the demand for liposuction surgery devices. More than 14 new energy-based devices were introduced in the EU market through the approval of the EU Medical Device Regulation in 2023. This is directed to higher adoption of the latest technology and advancement of the treatment to achieve better patient outcomes.
The liposuction surgery devices market in Germany is the dominant one in Europe. Higher government spending accelerated the market performance and encouraged patients to access the surgeries. Approximately €1 billion of government spending is ensured via public insurance. Demand for surgeries boosted by 19% with the G-BA extension of the coverage limit specifically for the high BMI patients in 2023. The public-private partnership spending is also comparatively high, with an estimated value of USD 3.9 billion, which advanced research and development for the liposuction surgery devices.
Key Liposuction Surgery Devices Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
A consolidated environment is experienced in the global liposuction surgery devices market. The U.S. and the EU are the leading players within the concerned market that advocate the usage of energy-based technology in the global platform. The key strategies incorporated by the business to gain a competitive edge include product innovation, market expansion in the emerging region, regulatory agility, and localized manufacturing. For instance, InMode launched their AI-assisted product BodyTite and Solta’s VASER 2.0, which specifically targeted the premium markets. Fosun Pharma invested to expand in expanding the low-cost disposable devices for the emerging markets of India and China. Government regulations in India and Malaysia created it as a manufacturing hub. The PLI scheme of India and the tax incentives of Malaysia attracted businesses to develop a manufacturing plant and produce an affordable range of products.
Here are some leading players in the liposuction surgery devices market:
|
Company Name |
Industry Focus |
Market Share (2024) |
|
InMode Ltd. (U.S.) |
Energy-based devices |
18.6% |
|
Johnson & Johnson (Mentor) (U.S.) |
Liposuction cannulas, VASER systems |
15.3% |
|
Bausch Health (Solta Medical) (Canada) |
Laser-assisted lipo |
12.5% |
|
Sciton Inc. (U.S.) |
Hyper-targeted laser lipolysis |
10.2% |
|
Wells Johnson Co. (U.S.) |
isposable cannulas, aspiration pumps |
8.4% |
|
Human Med AG (Germany) |
Power-assisted liposuction (PAL) devices |
xx% |
|
Fosun Pharma (China) |
Low-cost portable systems for emerging markets |
xx% |
|
Medicinos Linija (Lithuania) |
Tumescent liposuction kits |
xx% |
|
MicroAire (U.S.) |
PAL and ultrasonic liposuction devices |
xx% |
|
Euromi (Belgium) |
Cryolipolysis and RF-assisted lipo (Aqualyx) |
xx% |
|
YOLO Medical (South Korea) |
Non-invasive laser lipo |
xx% |
|
Hironic Co. (South Korea) |
High-frequency ultrasound-assisted devices |
xx% |
|
Meditrina Inc. (India) |
Budget-friendly disposable cannulas |
xx% |
|
Lumenis (Israel) |
Laser systems |
xx% |
|
Alma Lasers (Israel) |
Hybrid energy-based platforms |
xx% |
|
Zimmer Biomet (U.S.) |
Power-assisted liposuction |
xx% |
|
Cynosure (U.S.) |
Affordable SCD drugs |
xx% |
|
Bioverativ (U.S.) |
SmartLipo laser systems |
xx% |
|
Venus Concept (Canada) |
RF-assisted lipo |
xx% |
|
Misonix (USA) |
Ultrasonic liposuction |
xx% |
|
Sinclair Pharma (UK) |
Injectable fat-dissolving treatments |
xx% |
Below are the areas covered for each company in the liposuction surgery devices market:
Recent Developments
- In March 2024, InMode introduced the Evoke II System, which is a next-generation radio frequency-integrated device for liposuction surgery. This enabled the business to gain over 14% of the U.S. market in three months.
- In May 2024, Bausch Health launched VASER 3.0, which is developed to an ultrasonic liposuction device system with an ability to emulsification of fat at a rate of 28% faster than other devices.
- Report ID: 68
- Published Date: Jun 20, 2025
- Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Liposuction Surgery Devices Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
Copyright @ 2025 Research Nester. All Rights Reserved.
